NEW YORK (GenomeWeb) – As the CRISPR-Cas9 gene editing technology sets to take off, the patent landscape surrounding the method has quickly become muddled with stakeholders seeking a claim to what some are calling a foundational technology.
Registering provides access to this and other free content.
Already have an account?Login Now.
In PNAS this week: human cytomegalovirus diversity, patterns of homologous recombination in E. coli, and more.
US lawmakers are considering eliminating the medical devices tax that is part of the Affordable Care Act.
Two research teams in China home in on a gene that gives rice a long, slender shape.
Marcia McNutt, the editor-in-chief of Science, has been nominated to become president of the US National Academy of Sciences.